endralazine
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
SummaryFive and 10 mg single oral doses of a new vasodilator antihypertensive, endralazine (E) were given on separate occasions…
SummaryA sensitive HPLC assay has been used to determine the effect of food on plasma endralazine levels in 8 patients with…
SummaryNineteen out-patients with moderate to severe essential hypertension were treated daily for 3 years, with an average dose…
The direct-acting vasodilator, endralazine, in combination with a beta-adrenoceptor blocker significantly reduced the blood…
Endralazine (BQ 22–708, Miretilan) and guanfacine (BS 100–141, Estulic) were tested alone and in combination for their effects on…
In the treatment of severe hypertension the choice of vasodilator is limited by side-effects, of which the lupus erythematosus…
Three antihypertensive hydrazine derivatives (hydralazine, dihydralazine, and endralazine) were found to be genotoxic in four in…
In a randomized cross-over trial in 23 patients with essential hypertension, a new peripheral vasodilator, endralazine, in a dose…
1. The effects on blood pressure, heart rate and plasma renin activity of a new hydralazine congener, endralazine, were evaluated…